文献速递神经头颈外周血管CT

光子计数探测器CT头颈部血管成像中降低辐射剂量与对比剂用量:与能量积分探测器CT的比较

Reduction of Radiation Dose and Contrast Medium Volume in Photon-Counting Detector Computed Tomography Head and Neck Angiography: A Comparison to Energy-Integrating Detector Computed Tomography.
PubMed 文献 · Acad Radiol · 2025-07-28

该回顾性队列研究纳入150例脑血管病患者,比较常规能量积分探测器CT标准对比剂方案与光子计数探测器CT「四低」策略(超低对比剂剂量、低对比剂浓度、低注射流率、低辐射剂量)的头颈部血管成像质量。结果显示「四低」方案对比剂中位用量降低>30%、对比剂浓度降低9%、注射流率降低10%(均p<0.001),EG2组有效辐射剂量降低28%(p<0.001),图像质量与其他组相当(p>0.05),主观评分中位Likert 4分(IQR 4-5),观察者间一致性优良(κ=0.814-0.934)。作者认为该方案可能成为脑血管评估中更安全的替代选择。

要点

  • 「四低」PCD-CT方案对比剂中位用量降低>30%、浓度降低9%、流率降低10%(均p<0.001)。
  • EG2组有效辐射剂量降低28%(p<0.001),图像质量与其他组相当(p>0.05)。
  • 主观图像质量各组中位Likert评分4分(IQR 4-5),观察者间一致性κ=0.814-0.934。

核心结论

  • PCD-CT采用「四低」策略可在对比剂用量和辐射暴露大幅降低的情况下完成神经血管成像,图像质量与常规EID-CT相当,该方案可能成为脑血管常规评估中更安全的替代选择。

研究设计与样本

  • 回顾性队列研究,共纳入150例脑血管病患者;对照组50例接受EID-CT标准对比剂方案(对比剂剂量:体重×0.6 mL/kg),两个前瞻性队列各50例接受PCD-CT优化对比剂方案(对比剂剂量:体重×0.4 mL/kg;注射流率:对比剂剂量/[延迟时间+扫描时间]),分别为EG1和EG2,EG2辐射剂量较EG1进一步降低。

关键影像表现/征象

  • EG1和EG2较对照组血管衰减显著改善、图像噪声降低、SNR和CNR提高。
  • 各组主观图像质量均评为高分,中位Likert评分4分(IQR 4-5),观察者间一致性优良(κ=0.814-0.934)。
  • EG2在维持图像质量与其他组相当(p>0.05)的同时,表现出更大的辐射剂量降低潜力。

诊断标准与关键数值

  • 对比剂方案:对照组为体重×0.6 mL/kg;EG1和EG2为体重×0.4 mL/kg,注射流率=对比剂剂量/[延迟时间+扫描时间]。
  • 与对照组相比,EG1和EG2对比剂中位用量降低>30%、对比剂浓度降低9%、注射流率降低10%(均p<0.001)。
  • EG2有效辐射剂量降低28%(p<0.001),图像质量与其他组相当(p>0.05)。
  • 主观图像质量采用5分Likert量表评估,各组中位评分4分(IQR 4-5),观察者间一致性κ=0.814-0.934。

临床应用与阅片要点

  • 作者认为该「四低」PCD-CT方案可能作为脑血管常规评估中更安全的替代选择。
  • 阅片时可关注PCD-CT在降低对比剂用量和辐射剂量条件下仍能维持血管衰减、SNR和CNR。
  • 主观评分采用5分Likert量表,各组中位4分(IQR 4-5),观察者间一致性κ=0.814-0.934,提示诊断信心高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This study evaluated the image quality of photon-counting detector computed tomography (PCD-CT) for head and neck vascular imaging using the "Quadruple Low" strategy (ultra-low contrast dose, low contrast concentration, low injection rate, and low radiation dose). The results were compared with those from conventional energy-integrating detector computed tomography (EID-CT) performed using routine scanning parameters.

MATERIALS AND METHODS: This retrospective cohort study included 50 patients with cerebrovascular disease who underwent EID-CT with a standard contrast protocol (contrast dose: body weight × 0.6 mL/kg), serving as the control group (CG). Two prospective cohorts, each comprising 50 patients, underwent PCD-CT with an optimized contrast protocol (contrast dose: body weight × 0.4 mL/kg; injection rate: contrast dose/[delay time + scan duration]), forming the experimental groups (EG1 and EG2). In EG2, the radiation dose was further reduced relative to that in EG1. Objective image quality was assessed by measuring vascular attenuation, image noise, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). Subjective image quality was evaluated using a 5-point Likert scale.

RESULTS: This study included 150 patients (86 men; mean age, 56.03 ± 11.10 years; mean body mass index[BMI], 24.28 ± 3.03 kg/m²). Compared with the CG, the optimized contrast protocol in EG1 and EG2 reduced the median contrast volume by >30%, decreased the contrast concentration by 9%, and lowered the injection flow rate by 10% (all p < 0.001). The effective radiation dose in EG2 was reduced by 28% (p < 0.001) while maintaining image quality comparable to that of other groups (p > 0.05). EG2 exhibited a greater potential for radiation dose reduction. EG1 and EG2 exhibited significant improvements in vascular attenuation, reduced image noise, and enhanced SNR and CNR. Subjective image quality was consistently rated as high across all groups, with a median Likert score of 4 (IQR: 4-5), and excellent interobserver agreement (κ = 0.814-0.934), indicating consistently high diagnostic confidence.

CONCLUSION: PCD-CT using the "Quadruple Low" strategy enables neurovascular imaging with substantially reduced contrast media and radiation exposure, while maintaining image quality comparable to conventional EID-CT. This protocol may serve as a safer alternative in routine cerebrovascular evaluation.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang M, Nie K, Yuan D, et al. Reduction of Radiation Dose and Contrast Medium Volume in Photon-Counting Detector Computed Tomography Head and Neck Angiography: A Comparison to Energy-Integrating Detector Computed Tomography. Acad Radiol. 2025. PMID: 40730780. doi:10.1016/j.acra.2025.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。